US EditionCardurion concludes enrolment in Phase II trials for heart failure treatment
Summary by Clinical Trials Arena
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Cardurion concludes enrolment in Phase II trials for heart failure treatment
Cardurion has completed enrolment in two multicentre, global Phase II CYCLE trials of CRD-750, targeting both chronic HF types.The post Cardurion concludes enrolment in Phase II trials for heart failure treatment appeared first on Clinical Trials Arena.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium